Page 7 - Michael Vi News Today

Merck's (MRK) Q2 sales grew 28% Y/Y on the back of COVID therapy Lagevrio and blockbuster cancer drug Keytruda while also raising and narrowing its FY22 outlook.Q2 total sales grew...

Merck's (MRK) blockbuster drug Keytruda did not meet the main goal of event-free survival ((EFS)) in a phase 3 trial in patients with w type of head and neck cancer.The...

Palantir stock has outperformed the market since we published our previous Buy rating. Read why the market has priced in a recessionary scenario for PLTR.

Naspers' plan creates a lot of uncertainty for Tencent's (TCEHY) stock as the share sales could go on for years. Click here to know more...

LendingClub trades at 7-8x 2022 earnings, despite a clear path to grow earnings by double digits. Click here to read more about this long-term growth stock.

ASML Holdings (ASML) fell more than 7% on Tuesday after Bloomberg reported that the U.S. government is trying to get the semiconductor equipment company to stop selling its tools to China.

Tencent (TCHEY) and TikTok parent ByteDance (BDNCE) have started to lay off employees in China as growth stalls, impacting thousands of employees, according to The Wall Street...

Investors are facing a perfect storm due to 40-year high inflation and fears of an upcoming recession. Read why SRE is immune to inflation and recessions.

This is a dedicated price action analysis of Palo Alto stock. We note that PANW is at a near-term bottom. Read what investors need to know about PANW here.

Tencent shareholders have suffered multiple headwinds in the past 12 months. Check out why I assign a Buy recommendation for Tencent stock.